PAGE Therapeutics AG
PrivateLast Round
Seed
Oct 25, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PAGE Therapeutics AG is a biotechnology company that operates a platform for oncology drug development intended to discover and commercialize anti-metastatic compounds.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PAGE Therapeutics AG Comparables
Compare PAGE Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZielBio | 64% | |
| Novartis | 62% | |
| Boehringer Ingelheim | 62% |
PAGE Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 25, 2024 | ||||
| Early Funding | May 11, 2023 | ||||
| Seed | Mar 1, 2023 |
PAGE Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ETH Zurich | Early Funding, Seed |
| XGEN Venture | Early Funding, Seed |
| Kizoo Technology Capital | Seed, Early Funding |
| Claris Ventures | Seed, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 793% MoM, from 122 to 1.1K.
- Mar 1, 2023
Seed round raised with participation from Claris Ventures and Kizoo Technology Capital.
PAGE Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PAGE Therapeutics AG's valuation, stock price, and market status.
Is PAGE Therapeutics AG a public or private company?
PAGE Therapeutics AG is a private company.
What is the current stock price of PAGE Therapeutics AG?
PAGE Therapeutics AG is a private company with no public stock price. No recent secondary market data is available.
How much is PAGE Therapeutics AG worth (valuation)?
Valuation information for PAGE Therapeutics AG is not publicly available.
Can I buy PAGE Therapeutics AG stock?
PAGE Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PAGE Therapeutics AG's last funding round?
PAGE Therapeutics AG's most recent funding round was Seed on October 25, 2024.
Who are the main investors in PAGE Therapeutics AG?
Key investors in PAGE Therapeutics AG include XGEN Venture, Claris Ventures.
Will PAGE Therapeutics AG IPO soon?
No public IPO plans have been announced for PAGE Therapeutics AG.
How can I track PAGE Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PAGE Therapeutics AG's secondary market activity and sign up for updates.